Lakeshore Biopharma Co, Stock Today
| LSB Stock | 2.75 0.23 7.72% |
Performance0 of 100
| Odds Of DistressOver 85
|
LakeShore Biopharma is trading at 2.75 as of the 2nd of December 2024, a 7.72 percent decrease since the beginning of the trading day. The stock's open price was 2.98. LakeShore Biopharma has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. LakeShore Biopharma symbol was changed from YS on 28th of May 2024. Equity ratings for LakeShore Biopharma Co, are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of November 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 16th of March 2023 | Category Healthcare | Classification Health Care |
LakeShore Biopharma is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 190.81 M outstanding shares of which 47.52 K shares are now shorted by investors with about 1.07 days to cover. More on LakeShore Biopharma Co,
Moving together with LakeShore Stock
| 0.79 | ME | 23Andme Holding Upward Rally | PairCorr |
Moving against LakeShore Stock
LakeShore Stock Highlights
| Older Symbol | YS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CoCEO Board | Dave Chenn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LakeShore Biopharma can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand LakeShore Biopharma's financial leverage. It provides some insight into what part of LakeShore Biopharma's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LakeShore Biopharma Co, (LSB) is traded on NASDAQ Exchange in USA. It is located in Building No. 2, Beijing, China, 102629 and employs 758 people. LakeShore Biopharma Co, was previously known as YS Biopharma Co, and was traded on NASDAQ Exchange under the symbol YS. LakeShore Biopharma is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 114.29 M. LakeShore Biopharma Co, runs under Biotechnology sector within Health Care industry. The entity has 190.81 M outstanding shares of which 47.52 K shares are now shorted by investors with about 1.07 days to cover.
LakeShore Biopharma generates negative cash flow from operations
Check LakeShore Biopharma Probability Of Bankruptcy
Ownership AllocationLakeShore Biopharma Co, maintains a total of 190.81 Million outstanding shares. LakeShore Biopharma Co, secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.34 % of LakeShore Biopharma Co, outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check LakeShore Ownership Details
LakeShore Biopharma Historical Income Statement
LakeShore Stock Against Markets
LakeShore Biopharma Corporate Management
| Yuan Liu | Head Research | Profile | |
| Zenaida MD | Chief Officer | Profile | |
| Gang Li | Head Sales | Profile | |
| Zhiyuan Ran | Head Department | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 5.363 | Quarterly Revenue Growth 0.277 | Return On Assets (0.14) | Return On Equity (0.66) |
The market value of LakeShore Biopharma Co, is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.